An experimental vaccine aimed at preventing fentanyl overdoses showed promise in an early-stage clinical trial, according to the drugmaker, ARMR Sciences. NBC News’ Berkeley Lovelace Jr. explains how this breakthrough could combat the opioid crisis. An experimental vaccine aimed at preventing fentanyl overdoses showed promise in an early-stage clinical trial, according to the drugmaker, ARMR Sciences. NBC News’ Berkeley Lovelace Jr. explains how this breakthrough could combat the opioid crisis.
Experimental fentanyl vaccine showed promise in an early-stage trialExperimental fentanyl vaccine showed promise in an early-stage trial
